Genprex Depreciation Amortization and Accretion from 2010 to 2024
| GNPX Stock | USD 2.35 0.33 12.31% |
Check Genprex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genprex main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 K, Selling General Administrative of 9.2 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.61. Genprex financial statements analysis is a perfect complement when working with Genprex Valuation or Volatility modules.
Genprex | Depreciation Amortization and Accretion |
About Genprex Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Genprex income statement, its balance sheet, and the statement of cash flows. Genprex investors use historical funamental indicators, such as Genprex's Depreciation Amortization and Accretion, to determine how well the company is positioned to perform in the future. Although Genprex investors may use each financial statement separately, they are all related. The changes in Genprex's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Genprex's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Genprex Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Genprex. Please read more on our technical analysis and fundamental analysis pages.
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Genprex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genprex in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genprex's short interest history, or implied volatility extrapolated from Genprex options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Genprex Correlation against competitors. For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Genprex Stock analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Genprex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genprex. If investors know Genprex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genprex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (22.56) | Return On Assets (1.09) | Return On Equity (2.08) |
The market value of Genprex is measured differently than its book value, which is the value of Genprex that is recorded on the company's balance sheet. Investors also form their own opinion of Genprex's value that differs from its market value or its book value, called intrinsic value, which is Genprex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genprex's market value can be influenced by many factors that don't directly affect Genprex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genprex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genprex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genprex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.